Spring Valley is an AAALACi-accredited, service-oriented contract research company with more than 20 years of experience supporting basic research efforts and specializing in in vivo preclinical vaccine and biological product development. We can help you answer a variety of questions from the very basic questions of “Can you make an antibody to this substance?” and “Does this substance elicit an immune response?” to the far more complex questions of “Are there any adverse effects in animals to administration of this substance?”, and “Is this lot as ‘safe’ as the previous lot?”. SVL can also help you create any necessary immunological reagents and/or test methods that you may need. We address these questions through:

• exploratory stage immunogenicity studies
• developing reagents for in vivo and in vitro assays conducted at your facility or ours
• custom polyclonal antibody development
• custom monoclonal antibody development
• monoclonal antibodies to rabbit proteins (in stock)
• conducting GLP-compliant safety (toxicity) studies for IND submissions
• performing in vivo product release testing
• providing other services

Spring Valley, Inc. Undergoes Successful FDA Audit

Highly Specific Antibodies with High Titers

SVL now offers polyclonal antibody services utilizing allotype-defined rabbits developed by NIAID.  These rabbits produce highly specific antibodies with high titers.

When ordering a polyclonal project at SVL, you now have the option to use:
allotype-defined rabbits, New Zealand white rabbits, or a combination of the New Zealand and the Allotype-defined Rabbits to broaden your potential response.

For a detailed description of these unique rabbits, please click the link below:
Allotype Defined Pedigreed Rabbits.pdf

Contact us for details and/or a quotation.  We look forward to providing you with a great antibody response.